Gadolinium as an element for neutron capture therapy

Simple item page
dc.contributor.authorBrugger, RMen_AU
dc.contributor.authorLiu, HBen_AU
dc.contributor.authorLaster, BHen_AU
dc.contributor.authorGordon, CRen_AU
dc.contributor.authorGreenberg, DDen_AU
dc.contributor.authorWarkentien, LSen_AU
dc.date.accessioned2026-01-06T04:52:39Zen_AU
dc.date.available2026-01-06T04:52:39Zen_AU
dc.date.issued1993en_AU
dc.date.statistics2025-12-16en_AU
dc.descriptionPhysical copy held by ANSTO Library at DDC. 616.9940642/3en_AU
dc.description.abstractGadolinium is being studied as an alternate active element to B for Neutron Capture Therapy (NCT). The advantages of Gd-157 as compared to B-10 are that Gd-157 has a very large thermal neutron cross section (455,000 b), and Gd containing compounds that target tumors are being developed as MRI contrast agents. A disadvantage is that the products of the Gd + n reaction, gamma rays and Auger electrons, do not appear to be as well suited to NCT as the products of the B + n reaction, but these still may be effective in destroying tumors. Because of the advantages of Gd, an investigation of Gd as an element for NCT is proceeding at Brookhaven National Laboratory (BNL)1. © Plenum Pressen_AU
dc.identifier.booktitleAdvances in Capture Therapy for Canceren_AU
dc.identifier.citationBrugger, R. M., Liu, H. B., Laster, B. H., Gordon, C. R., Greenberg, D. D., & Warkentien, L. S. (1992). Gadolinium as an element for neutron capture therapy. Paper presented to the Fifth International Symposium on Neutron Capture Therapy for Cancer, September 13-17, Columbus, Ohio, USA. In Soloway, A. H., Barth, R. F., Carpenter, D. E. (eds) Advances in Neutron Capture Therapy, (pp. 225-229). Boston, MA : Plenum Press.en_AU
dc.identifier.conferenceenddate1992-09-17en_AU
dc.identifier.conferencenameFifth International Symposium on Neutron Capture Therapy for Canceren_AU
dc.identifier.conferenceplaceColumbus, Ohioen_AU
dc.identifier.conferencestartdate1992-09-16en_AU
dc.identifier.editorsSoloway, A. H., Barth, R. F., & Carpenter, D. E.en_AU
dc.identifier.isbn0306445670en_AU
dc.identifier.pagination225-229en_AU
dc.identifier.urihttps://apo.ansto.gov.au/handle/10238/16833en_AU
dc.language.isoenen_AU
dc.publisherPlenum Pressen_AU
dc.subjectAuger effecten_AU
dc.subjectDTPAen_AU
dc.subjectEpithermal neutronsen_AU
dc.subjectGadolinium 157en_AU
dc.subjectGadolinium compoundsen_AU
dc.subjectNeutron capture therapyen_AU
dc.subjectRadiopharmaceuticalsen_AU
dc.subjectToxicityen_AU
dc.titleGadolinium as an element for neutron capture therapyen_AU
dc.typeConference Paperen_AU
Files
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.63 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Conference Publications